Lataa...
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
Emerging evidence suggests that soluble epoxide hydrolase (sEH) inhibition is a valuable therapeutic strategy for the treatment of numerous diseases, including those of the liver. sEH rapidly degrades cytochrome P450-produced epoxygenated lipids (epoxy-fatty acids), which are synthesized from omega-...
Tallennettuna:
| Julkaisussa: | Biology (Basel) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7345757/ https://ncbi.nlm.nih.gov/pubmed/32545637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology9060124 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|